Next Article in Journal
Four Decades of COPD Mortality Trends: Analysis of Trends and Multiple Causes of Death
Next Article in Special Issue
The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still’s Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets
Previous Article in Journal
Trends of COVID-19 Admissions in an Italian Hub during the Pandemic Peak: Large Retrospective Study Focused on Older Subjects
Previous Article in Special Issue
Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach
 
 
Registered Report
Peer-Review Record

Comparing the Clinical and Laboratory Features of Remitting Seronegative Symmetrical Synovitis with Pitting Edema and Seronegative Rheumatoid Arthritis

J. Clin. Med. 2021, 10(5), 1116; https://doi.org/10.3390/jcm10051116
by Misako Higashida-Konishi 1,*, Keisuke Izumi 1,2, Satoshi Hama 1, Hiroshi Takei 1, Hisaji Oshima 1 and Yutaka Okano 1
Reviewer 1:
Reviewer 2:
J. Clin. Med. 2021, 10(5), 1116; https://doi.org/10.3390/jcm10051116
Submission received: 25 January 2021 / Revised: 25 February 2021 / Accepted: 4 March 2021 / Published: 7 March 2021
(This article belongs to the Special Issue Systemic Autoinflammatory Diseases—Clinical Rheumatic Challenges)

Round 1

Reviewer 1 Report

Dear authors, 

Thank you for your time and effort to prepare the manuscript. The article has significant clinical relevance, although it could be improved in several instances please see my suggestions below: 

1.Table 1: I suggest to provide this table in the supplementary materials and replace it with a table specifying the descriptive statistic ie. mean, n (%)

2. Figure 1 A: I did not find figure 1 A informative. it could be removed or palced in the supplementary materials. 

3. statistics: Please report all significant results with 3 decimals and non significant results with two decimals in all tables for consistency. 

Besides, please add how you treated missing values in the study. 

4. Table 7: please provide statistic results for table 7, and the overall significance for the model you have reported. Please add to statistic section how you built the regression model. Is this based on the clinical relevance? or based on the all available data. 

5. at last, I suggest to report most important results in the main text and place other results in the supplementary materials. 

Sincerely yours 

Author Response

Thank you very much for your comments.

 

Point 1:

Table 1: I suggest to provide this table in the supplementary materials and replace it with a table specifying the descriptive statistic ie. mean, n (%)

 

Response 1:

I agree with you.

Table 1 was moved to supplementary materials. The descriptive statistic of the 24 patients with RS3PE and 124 patients with seronegative RA was shown in Table 1.

 

Point 2:

Figure 1 A: I did not find figure 1 A informative. it could be removed or palced in the supplementary materials.

 

Response 2:

Figure 1 A was moved to supplementary materials.

 

Point 3:

statistics: Please report all significant results with 3 decimals and non significant results with two decimals in all tables for consistency.

 

Besides, please add how you treated missing values in the study.

 

Response 3:

We agree with you. In the case of missing data, the number of patient with available data was specified. We added the following in the manuscript: In the case of missing data, the number of patient with available data was specified(p.3, l.120). We showed the number of patient with available data in Tables.

 

Point 4: Table 7: please provide statistic results for table 7, and the overall significance for the model you have reported. Please add to statistic section how you built the regression model. Is this based on the clinical relevance? or based on the all available data.

 

Response 4:

This is not the result of multiple logistic regression analysis, but of univariate analysis. There were 14 patients with malignancy. Only univariate analysis was possible because of small sample size.

The following has been added to the manuscript (p. 3, l. 116-120)(p. 8, l. 208).

 

  1. 3, l. 116-120: The odds ratio(OR) and its 95% confidence interval (95% CI) indicate the increased or decreased risk of malignancy associated with a one-unit change in the predictor variable for continuous variables. For dichotomous variables, the OR indicate the risk of malignancy associated with the presence of the characteristic compared to the absence of the characteristic.

 

  1. 8, l. 208: Table 5. Risk factors for malignancy in patients with RS3PE or seronegative RA analyzed by univariate logistic regression analysis

 

 

 

Point 5: at last, I suggest to report most important results in the main text and place other results in the supplementary materials.

 

Response 5:

I agree with you.

Table 1, 2, 8, and 9 were moved to supplementary materials.

Reviewer 2 Report

The authors investigated the clinical difference between RS3PE and seronegative RA. This manuscript is valuable because these two disease sometimes show similar clinical manifestation and difficult to different diagnosis.

 The number of RS3PE patients were small, but the conclusion provides useful information for clinicians. Moreover, the discussion and methodology were written appropriately.    

Author Response

Comments:

The authors investigated the clinical difference between RS3PE and seronegative RA. This manuscript is valuable because these two disease sometimes show similar clinical manifestation and difficult to different diagnosis.

 

 The number of RS3PE patients were small, but the conclusion provides useful information for clinicians. Moreover, the discussion and methodology were written appropriately.  

 

Response:

Thank you very much for your comments. We are thankful for the time and energy you expended.

Round 2

Reviewer 1 Report

Dear authors, 

Thanks for the revised version. It improved significantly. I have no further comments.

Best

Back to TopTop